INNOVEX INTERNATIONAL INC (INVX) Fundamental Analysis & Valuation

NYSE:INVX • US4576511079

Current stock price

28.15 USD
+0.1 (+0.36%)
At close:
28.15 USD
0 (0%)
After Hours:

This INVX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. INVX Profitability Analysis

1.1 Basic Checks

  • INVX had positive earnings in the past year.
  • In the past year INVX had a positive cash flow from operations.
  • In multiple years INVX reported negative net income over the last 5 years.
  • INVX had a positive operating cash flow in 4 of the past 5 years.
INVX Yearly Net Income VS EBIT VS OCF VS FCFINVX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 6.57%, INVX belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 7.88%, INVX is in the better half of the industry, outperforming 72.58% of the companies in the same industry.
  • INVX's Return On Invested Capital of 8.28% is fine compared to the rest of the industry. INVX outperforms 75.81% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for INVX is in line with the industry average of 6.92%.
  • The last Return On Invested Capital (8.28%) for INVX is above the 3 year average (5.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROIC 8.28%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
INVX Yearly ROA, ROE, ROICINVX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 -5 10 -10

1.3 Margins

  • The Profit Margin of INVX (8.51%) is better than 75.81% of its industry peers.
  • With a decent Operating Margin value of 11.63%, INVX is doing good in the industry, outperforming 64.52% of the companies in the same industry.
  • INVX has a Gross Margin of 31.00%. This is in the better half of the industry: INVX outperforms 72.58% of its industry peers.
  • INVX's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.63%
PM (TTM) 8.51%
GM 31%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
INVX Yearly Profit, Operating, Gross MarginsINVX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. INVX Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so INVX is destroying value.
  • INVX has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for INVX has been increased compared to 5 years ago.
  • Compared to 1 year ago, INVX has an improved debt to assets ratio.
INVX Yearly Shares OutstandingINVX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
INVX Yearly Total Debt VS Total AssetsINVX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 7.41 indicates that INVX is not in any danger for bankruptcy at the moment.
  • The Altman-Z score of INVX (7.41) is better than 98.39% of its industry peers.
  • The Debt to FCF ratio of INVX is 0.16, which is an excellent value as it means it would take INVX, only 0.16 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.16, INVX belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
  • A Debt/Equity ratio of 0.02 indicates that INVX is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.02, INVX belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Altman-Z 7.41
ROIC/WACC0.93
WACC8.89%
INVX Yearly LT Debt VS Equity VS FCFINVX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M 1B

2.3 Liquidity

  • INVX has a Current Ratio of 4.91. This indicates that INVX is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 4.91, INVX belongs to the top of the industry, outperforming 96.77% of the companies in the same industry.
  • A Quick Ratio of 3.24 indicates that INVX has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.24, INVX belongs to the best of the industry, outperforming 95.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.91
Quick Ratio 3.24
INVX Yearly Current Assets VS Current LiabilitesINVX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. INVX Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 382.35% over the past year.
  • INVX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 74.11% yearly.
  • INVX shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.86%.
  • Measured over the past years, INVX shows a very strong growth in Revenue. The Revenue has been growing by 21.80% on average per year.
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%

3.2 Future

  • INVX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.83% yearly.
  • Based on estimates for the next years, INVX will show a small growth in Revenue. The Revenue will grow by 4.22% on average per year.
EPS Next Y51.73%
EPS Next 2Y39.21%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue Next Year3.85%
Revenue Next 2Y4.57%
Revenue Next 3Y4.22%
Revenue Next 5YN/A

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
INVX Yearly Revenue VS EstimatesINVX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
INVX Yearly EPS VS EstimatesINVX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. INVX Valuation Analysis

4.1 Price/Earnings Ratio

  • INVX is valuated quite expensively with a Price/Earnings ratio of 29.32.
  • Compared to the rest of the industry, the Price/Earnings ratio of INVX indicates a somewhat cheap valuation: INVX is cheaper than 67.74% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 26.91. INVX is around the same levels.
  • A Price/Forward Earnings ratio of 19.33 indicates a rather expensive valuation of INVX.
  • Based on the Price/Forward Earnings ratio, INVX is valued a bit cheaper than 67.74% of the companies in the same industry.
  • INVX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.99.
Industry RankSector Rank
PE 29.32
Fwd PE 19.33
INVX Price Earnings VS Forward Price EarningsINVX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • INVX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, INVX is valued cheaply inside the industry as 82.26% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 12.39
EV/EBITDA 10
INVX Per share dataINVX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of INVX may justify a higher PE ratio.
  • INVX's earnings are expected to grow with 26.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.57
PEG (5Y)0.4
EPS Next 2Y39.21%
EPS Next 3Y26.83%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INVX Dividend Analysis

5.1 Amount

  • INVX does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INVX Fundamentals: All Metrics, Ratios and Statistics

INNOVEX INTERNATIONAL INC

NYSE:INVX (4/28/2026, 8:04:00 PM)

After market: 28.15 0 (0%)

28.15

+0.1 (+0.36%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)02-23
Earnings (Next)05-04
Inst Owners47.97%
Inst Owner Change-0.58%
Ins Owners1.52%
Ins Owner Change0.11%
Market Cap1.93B
Revenue(TTM)978.25M
Net Income(TTM)83.30M
Analysts80
Price Target30.94 (9.91%)
Short Float %N/A
Short Ratio4.77
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-27.3%
Min EPS beat(2)-62.53%
Max EPS beat(2)7.93%
EPS beat(4)1
Avg EPS beat(4)-25.34%
Min EPS beat(4)-62.53%
Max EPS beat(4)7.93%
EPS beat(8)2
Avg EPS beat(8)-131.99%
EPS beat(12)2
Avg EPS beat(12)-130.16%
EPS beat(16)4
Avg EPS beat(16)-71.22%
Revenue beat(2)2
Avg Revenue beat(2)16.02%
Min Revenue beat(2)8.43%
Max Revenue beat(2)23.61%
Revenue beat(4)3
Avg Revenue beat(4)8.69%
Min Revenue beat(4)-4.42%
Max Revenue beat(4)23.61%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)21.33%
PT rev (3m)21.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-23.9%
EPS NY rev (1m)-3.38%
EPS NY rev (3m)-10.69%
Revenue NQ rev (1m)0.43%
Revenue NQ rev (3m)2.67%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.1%
Valuation
Industry RankSector Rank
PE 29.32
Fwd PE 19.33
P/S 1.97
P/FCF 12.39
P/OCF 10.11
P/B 1.82
P/tB 2.29
EV/EBITDA 10
EPS(TTM)0.96
EY3.41%
EPS(NY)1.46
Fwd EY5.17%
FCF(TTM)2.27
FCFY8.07%
OCF(TTM)2.78
OCFY9.89%
SpS14.27
BVpS15.43
TBVpS12.28
PEG (NY)0.57
PEG (5Y)0.4
Graham Number18.2546 (-35.15%)
Profitability
Industry RankSector Rank
ROA 6.57%
ROE 7.88%
ROCE 10.15%
ROIC 8.28%
ROICexc 10.12%
ROICexgc 13.23%
OM 11.63%
PM (TTM) 8.51%
GM 31%
FCFM 15.92%
ROA(3y)6.11%
ROA(5y)1.09%
ROE(3y)7.53%
ROE(5y)1.62%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)5.92%
ROICexc(5y)N/A
ROICexgc(3y)7.49%
ROICexgc(5y)N/A
ROCE(3y)6.27%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.34%
GM growth 5Y3.49%
F-Score7
Asset Turnover0.77
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.16
Debt/EBITDA 0.11
Cap/Depr 57.84%
Cap/Sales 3.59%
Interest Coverage 111.19
Cash Conversion 109.41%
Profit Quality 187.02%
Current Ratio 4.91
Quick Ratio 3.24
Altman-Z 7.41
F-Score7
WACC8.89%
ROIC/WACC0.93
Cap/Depr(3y)69.66%
Cap/Depr(5y)61.2%
Cap/Sales(3y)4.45%
Cap/Sales(5y)4.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)382.35%
EPS 3YN/A
EPS 5Y74.11%
EPS Q2Q%2.86%
EPS Next Y51.73%
EPS Next 2Y39.21%
EPS Next 3Y26.83%
EPS Next 5YN/A
Revenue 1Y (TTM)26.86%
Revenue growth 3Y39.3%
Revenue growth 5Y21.8%
Sales Q2Q%9.14%
Revenue Next Year3.85%
Revenue Next 2Y4.57%
Revenue Next 3Y4.22%
Revenue Next 5YN/A
EBIT growth 1Y26.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.66%
EBIT Next 3Y28.79%
EBIT Next 5YN/A
FCF growth 1Y95.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.32%
OCF growth 3YN/A
OCF growth 5YN/A

INNOVEX INTERNATIONAL INC / INVX Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INNOVEX INTERNATIONAL INC?

ChartMill assigns a fundamental rating of 7 / 10 to INVX.


Can you provide the valuation status for INNOVEX INTERNATIONAL INC?

ChartMill assigns a valuation rating of 6 / 10 to INNOVEX INTERNATIONAL INC (INVX). This can be considered as Fairly Valued.


How profitable is INNOVEX INTERNATIONAL INC (INVX) stock?

INNOVEX INTERNATIONAL INC (INVX) has a profitability rating of 6 / 10.


Can you provide the financial health for INVX stock?

The financial health rating of INNOVEX INTERNATIONAL INC (INVX) is 9 / 10.


Can you provide the expected EPS growth for INVX stock?

The Earnings per Share (EPS) of INNOVEX INTERNATIONAL INC (INVX) is expected to grow by 51.73% in the next year.